Article
Nadir CA-125 Is Prognostic for Recurrence, but Not for Survival in Patients With Ovarian Cancer
2021-02-04
Abstract excerpt
<h4>Objective: </h4> of this study was to evaluate nadir CA-125 in patients with epithelial ovarian cancer . 168 patients, who achieved complete remission (no clinical and radiological signs, CA-125< 35 U/ml) after first line treatment were enrolled in the study. The relation between CA-125 and survival were examined using generalized additive models applied to the Cox proportional hazards model. The median CA-125...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2eb81693-6475-5f21-a692-c4db2b751b7e
- DOI
- 10.21203/rs.3.rs-136867/v1
